The global bronchoscopes market was valued at USD 3.46 billion in 2025 and is projected to grow from USD 3.8 billion in 2026 to USD 8.02 billion by 2034, expanding at a CAGR of 9.8% during 2026–2034. Market growth is supported by increasing cases of respiratory diseases, rising lung cancer prevalence, growing ICU admissions, and wider adoption of minimally invasive pulmonary diagnostic procedures.

• Market Size (2025): USD 3.46 Billion
• Market Size (2026): USD 3.8 Billion
• CAGR (Forecast Period): 9.8%
• Forecast Year: 2034
• Projected Market Size (2034): USD 8.02 Billion
• Dominant Region: North America
• Fastest Growing Region: Asia-Pacific

Market Overview

Bronchoscopes are flexible or rigid medical instruments used to examine the airways and lungs. They allow physicians to diagnose and treat respiratory conditions by viewing bronchial passages, collecting tissue samples, removing obstructions, and performing minimally invasive procedures.

The market is evolving rapidly with the integration of AI, robotic navigation, advanced imaging, single-use devices, and ultra-thin flexible scopes. Hospitals, diagnostic centers, and ambulatory surgical centers are investing in these technologies to improve early lung disease detection, procedural accuracy, infection control, and patient outcomes.

Growth Drivers

The rising burden of respiratory diseases is one of the strongest growth drivers for the bronchoscopes market. Increasing cases of COPD, asthma, pneumonia, tuberculosis, and lung cancer are creating higher demand for accurate airway examination and minimally invasive diagnosis.

AI-enabled CT–bronchoscopy fusion and robotic-assisted bronchoscopy are also accelerating market growth. These technologies improve lesion localization, enable precise biopsy of peripheral lung nodules, and support early-stage lung cancer detection. Growing adoption of systems from companies such as Olympus, Medtronic, Boston Scientific, and Intuitive Surgical is strengthening the clinical use of advanced bronchoscopy platforms.

Market Challenges

A shortage of skilled interventional pulmonologists remains a major restraint. Advanced bronchoscopy systems require expertise in robotic navigation, CT-guided image fusion, catheter steering, and real-time lesion targeting, which are not yet widely available across all healthcare settings.

High maintenance requirements also limit adoption. Robotic and video bronchoscopes require regular calibration, servicing, imaging sensor maintenance, and component replacement. These costs can be difficult for smaller hospitals and cost-sensitive healthcare systems.

Market Opportunities

The shift toward ambulatory surgical centers is creating strong opportunities for bronchoscope manufacturers. ASCs are increasingly adopting flexible and disposable bronchoscopes for outpatient diagnostic and minor therapeutic airway procedures, reducing hospital burden and improving patient turnaround.

Single-use bronchoscopes also offer major growth potential. Hospitals are adopting disposable scopes in ICU and emergency settings to reduce cross-contamination risks and improve infection-prevention protocols, especially for critically ill and immunocompromised patients.

Segment Analysis

By product type, the flexible bronchoscope segment is projected to grow strongly due to its use in diagnostic bronchoscopy, better patient comfort, and ability to access deeper bronchial pathways. The rigid segment continues to remain important for therapeutic procedures such as foreign body removal, tumor debulking, and airway obstruction management.

By usage, the reusable segment remains widely adopted in tertiary care hospitals due to long-term cost efficiency and high imaging performance. However, the disposable segment is gaining traction due to rising infection-control concerns and faster procedure turnaround.

By application, oncology held the largest market share of 37.22% in 2025, driven by rising lung cancer prevalence and increasing demand for early tumor detection. ICU airway management is also growing steadily due to rising cases of respiratory failure, pneumonia, COPD exacerbations, and acute respiratory distress.

By end user, hospitals accounted for 72.88% share in 2025, supported by high patient volumes, advanced bronchoscopy infrastructure, skilled specialists, and critical care facilities. Ambulatory surgical centers are expected to grow rapidly due to rising demand for cost-effective outpatient bronchoscopy.

Regional Analysis

North America dominated the global bronchoscopes market with a 42.14% share in 2025. The region benefits from advanced hospital infrastructure, strong adoption of AI-enabled bronchoscopy systems, high prevalence of lung cancer and COPD, and the presence of leading MedTech companies.

The United States remains a major contributor, supported by strong use of robotic bronchoscopy platforms, AI-based navigation systems, and advanced lung cancer diagnostic programs. Canada is also witnessing rising adoption of single-use bronchoscopes and digital bronchoscopy systems to improve infection control and airway management.

Asia-Pacific is expected to be the fastest-growing region, expanding at a CAGR of 9.45% during the forecast period. Growth is driven by rising respiratory disease burden, modernization of pulmonary diagnostic infrastructure, and increasing adoption of AI-enabled and robotic bronchoscopy technologies across China, Singapore, Australia, and other key markets.

Competitive Landscape

The bronchoscopes market is moderately consolidated, with established medical device companies competing through AI-assisted imaging, robotic navigation, single-use bronchoscopes, advanced visualization systems, and global regulatory approvals.

Key Players

• Olympus Corporation
• Boston Scientific Corporation
• FUJIFILM Holdings Corporation
• KARL STORZ SE & Co. KG
• Ambu A/S
• HOYA Corporation
• Teleflex Incorporated
• Medtronic plc
• Richard Wolf GmbH
• Cook Medical
• Smith & Nephew plc
• CONMED Corporation
• Stryker Corporation
• B. Braun Melsungen AG
• Verathon Inc.
• Cogentix Medical
• Broncus Medical Inc.
• NeoScope Inc.

Recent Developments

In October 2025, PENTAX Medical signed an asset purchase agreement with Merit Medical Systems to divest its C2 CryoBalloon therapeutic endoscopy product line and sharpen its focus on core flexible reusable endoscopy operations.

In September 2025, Olympus Corporation initiated a Class 1 device recall for its EVIS EXERA III bronchovideoscope and OES bronchofiberscope product lines to update safety instructions related to laser and high-frequency therapy use during bronchoscopy.

In August 2025, Body Vision Medical received pre-market approval from Singapore’s Health Sciences Authority for commercialization of its LungVision AI-powered bronchoscopy imaging platform in Singapore.

In August 2025, Shanghai AnQing Medical Instrument Co., Ltd. received U.S. FDA 510(k) clearance for its flexible bronchoscope product portfolio.

In August 2025, Zhejiang UE Medical Corp. obtained U.S. FDA 510(k) clearance for multiple UE BRONCHO single-use bronchoscopes and UE Display systems.

Click to Read the Complete Insights & Report:https://straitsresearch.com/report/bronchoscopes-market

Future Outlook

The bronchoscopes market is expected to grow steadily through 2034 as healthcare systems prioritize early lung cancer detection, minimally invasive diagnostics, ICU airway management, and infection-safe bronchoscopy procedures. AI-powered imaging, robotic navigation, disposable scopes, and ultra-thin flexible devices will continue reshaping pulmonary care. As hospitals and outpatient centers modernize respiratory diagnostics, bronchoscopes will remain critical tools for advanced airway examination and lung disease management.

About Straits Research

Straits Research is a global market intelligence and consulting company providing actionable insights, industry analysis, and strategic research across healthcare, technology, industrial, consumer, and emerging sectors. The company supports businesses, investors, and decision-makers with reliable market forecasts, competitive intelligence, growth opportunity analysis, and industry trend assessment.